ARCHIVES

Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 9 | September 26, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: Walter Lawrence, Reginald Ho Lead ACS; Henderson To Leave Dana-Farber for UCSF

November 22, 1991

ACS Says New Tax Policy Hurts Charity Funds

April 25, 1980

First NCI Director To Resign Due To Presidential Election?

December 15, 2000

NCI prepares for third hearing on conflicts of interest.

June 18, 2004

NIH Strategic Plan To be Unveiled In San Antonio

January 31, 1992

At Its Launch, STAR Trial Inherits Baggage Of Its Predecessor, P-1 Tamoxifin Study

June 4, 1999